European equities were mixed on Friday as investors digested the impact of newly enacted U.S. tariffs and monitored geopolitical developments. Higher tariff rates imposed by the Trump administration on several trading partners officially took effect at midnight, while confirmation from Moscow that Russian President Vladimir Putin and U.S. President Donald Trump are arranging a meeting has raised hopes for a possible ceasefire in Ukraine.

As of the latest trading, the French CAC 40 Index edged up by 0.1%, while both Germany’s DAX Index and the U.K.’s FTSE 100 Index slipped 0.1%.

On the economic side, France’s unemployment rate remained stable at 7.5% in the second quarter, in line with expectations, according to the country’s statistics agency INSEE. The number of unemployed individuals rose by 29,000 compared to the previous quarter, reaching a total of 2.4 million.

In corporate developments, British pharmaceutical company GSK (LSE:GSK) advanced after announcing it would receive $370 million through a patent litigation settlement in the U.S.

German real estate firm Deutsche Wohnen (TG:DWNE) also moved higher following a report showing a narrower first-half loss.

Dutch insurance and asset management group NN Group (EU:NN) jumped after posting first-half earnings that surpassed analyst estimates.

Conversely, German reinsurer Munich Re (TG:A2TSS7) saw its shares drop sharply after the company lowered its insurance revenue outlook for 2025.

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.
Some portions of this content may have been generated or assisted by artificial intelligence (AI) tools and been reviewed for accuracy and quality by our editorial team.